跳至主要内容
临床试验/CTRI/2026/01/100953
CTRI/2026/01/100953尚未招募3 期

An Open Label Randomised Controlled Clinical Study to evaluate the efficacy of Ayorajvyoshaadya Churna,Phaltrikaadi Kwatha and Virechana Karma in the Management of Pandu Roga w.s.r. to Iron Deficiency Anaemia

RGGPG Ayurvedic College and Hospital Paprola Distt Kangra1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年5月6日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1

研究概览

简要总结

i would like to publish my research trial after completion as soon as possible.A total of 30 subjects will be studied in 2 groups, 15 study subjects with Virechana Karma, Ayorajvyoshadya Churna 375mg twice a day after meal, Phalatrikadi Kwatha 50ml twice a day after meal and 15 study subjects will be ,managed with Ferrous Sulphate 200 mg once a day.The outcome will be analysed with both Subjective and Objective criteria with appropriate statiscal tool.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1 Individuals of either gender between the age of 18-60 years. 2 Patients who present with sign and symptoms of Pandu Roga w.s.r. to Iron Deficiency Anaemia as described in classical texts. 3 Patients having low haemoglobin concentration i.e. Hb gm% for male 8-12gm% and female 8-11gm%. 4 MCV.
  • below 70fl 5 Patients willing and able to participate for 12weeks duration.

排除标准

  • 1 Patients suffering from chronic respiratory, cardiac disorder, CKD, Diabetes Mellitus, Rheumatoid Arthritis 2 Patients suffering from other major illness like carcinoma, tuberculosis or any other condition considered to be unfit for enrolment on the trial.
  • 3 Hb lessthan 8 gm per dl.
  • 4 Iron deficiency due to loss of blood from intestine& other sites.
  • 5 Iron deficiency anaemia necessitates parental iron therapy.
  • 6 Intake of Iron supplement for 3months before the initiation of study.
  • 7 Participant with hepatic dysfunction (defined as AST &ALT, 2 times more of upper limit).
  • 8 Participant with renal dysfunction i.e., S.
  • creatinine level should not be more than 1.2mg per dl.
  • 9 Patients who are pregnant and lactating mothers 10 History of hypersensitivity to any of the trial drug or its ingredients.
  • 11 Individuals who have completed participation in any other clinical trial during the past three months.

研究者

发起方
RGGPG Ayurvedic College and Hospital Paprola Distt Kangra
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

ProfDr Vijay Chaudhary

Rajiv Gandhi Govt Post Graduate Ayuvedic College and Hospital Paprola

研究点 (1)

Loading locations...

相似试验